PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BIO vs. VOO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between BIO and VOO is 0.56, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.6

Performance

BIO vs. VOO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bio-Rad Laboratories, Inc. (BIO) and Vanguard S&P 500 ETF (VOO). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%15.00%20.00%25.00%AugustSeptemberOctoberNovemberDecember2025
16.41%
4.23%
BIO
VOO

Key characteristics

Sharpe Ratio

BIO:

0.29

VOO:

1.87

Sortino Ratio

BIO:

0.65

VOO:

2.50

Omega Ratio

BIO:

1.08

VOO:

1.35

Calmar Ratio

BIO:

0.14

VOO:

2.80

Martin Ratio

BIO:

0.83

VOO:

11.95

Ulcer Index

BIO:

11.64%

VOO:

1.98%

Daily Std Dev

BIO:

33.12%

VOO:

12.73%

Max Drawdown

BIO:

-76.26%

VOO:

-33.99%

Current Drawdown

BIO:

-57.41%

VOO:

-4.03%

Returns By Period

In the year-to-date period, BIO achieves a 7.06% return, which is significantly higher than VOO's -0.79% return. Over the past 10 years, BIO has underperformed VOO with an annualized return of 11.63%, while VOO has yielded a comparatively higher 13.25% annualized return.


BIO

YTD

7.06%

1M

4.59%

6M

16.41%

1Y

10.40%

5Y*

-1.36%

10Y*

11.63%

VOO

YTD

-0.79%

1M

-3.48%

6M

4.23%

1Y

23.66%

5Y*

13.95%

10Y*

13.25%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BIO vs. VOO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIO
The Risk-Adjusted Performance Rank of BIO is 5757
Overall Rank
The Sharpe Ratio Rank of BIO is 6161
Sharpe Ratio Rank
The Sortino Ratio Rank of BIO is 5454
Sortino Ratio Rank
The Omega Ratio Rank of BIO is 5353
Omega Ratio Rank
The Calmar Ratio Rank of BIO is 5656
Calmar Ratio Rank
The Martin Ratio Rank of BIO is 5959
Martin Ratio Rank

VOO
The Risk-Adjusted Performance Rank of VOO is 8181
Overall Rank
The Sharpe Ratio Rank of VOO is 8181
Sharpe Ratio Rank
The Sortino Ratio Rank of VOO is 7979
Sortino Ratio Rank
The Omega Ratio Rank of VOO is 8181
Omega Ratio Rank
The Calmar Ratio Rank of VOO is 8282
Calmar Ratio Rank
The Martin Ratio Rank of VOO is 8484
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BIO vs. VOO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Bio-Rad Laboratories, Inc. (BIO) and Vanguard S&P 500 ETF (VOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BIO, currently valued at 0.29, compared to the broader market-2.000.002.000.291.87
The chart of Sortino ratio for BIO, currently valued at 0.65, compared to the broader market-4.00-2.000.002.004.000.652.50
The chart of Omega ratio for BIO, currently valued at 1.08, compared to the broader market0.501.001.502.001.081.35
The chart of Calmar ratio for BIO, currently valued at 0.14, compared to the broader market0.002.004.006.000.142.80
The chart of Martin ratio for BIO, currently valued at 0.83, compared to the broader market0.0010.0020.000.8311.95
BIO
VOO

The current BIO Sharpe Ratio is 0.29, which is lower than the VOO Sharpe Ratio of 1.87. The chart below compares the historical Sharpe Ratios of BIO and VOO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
0.29
1.87
BIO
VOO

Dividends

BIO vs. VOO - Dividend Comparison

BIO has not paid dividends to shareholders, while VOO's dividend yield for the trailing twelve months is around 1.25%.


TTM20242023202220212020201920182017201620152014
BIO
Bio-Rad Laboratories, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VOO
Vanguard S&P 500 ETF
1.25%1.24%1.46%1.69%1.25%1.54%1.88%2.06%1.78%2.02%2.10%1.85%

Drawdowns

BIO vs. VOO - Drawdown Comparison

The maximum BIO drawdown since its inception was -76.26%, which is greater than VOO's maximum drawdown of -33.99%. Use the drawdown chart below to compare losses from any high point for BIO and VOO. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-57.41%
-4.03%
BIO
VOO

Volatility

BIO vs. VOO - Volatility Comparison

Bio-Rad Laboratories, Inc. (BIO) has a higher volatility of 7.53% compared to Vanguard S&P 500 ETF (VOO) at 4.65%. This indicates that BIO's price experiences larger fluctuations and is considered to be riskier than VOO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%AugustSeptemberOctoberNovemberDecember2025
7.53%
4.65%
BIO
VOO
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab